Italia markets closed

BMY Jan 2026 40.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
3,5000-0,2000 (-5,41%)
Alla chiusura: 01:58PM EDT
Schermo intero
Chiusura precedente3,7000
Aperto3,5000
Denaro3,4000
Lettera3,8500
Prezzo d'esercizio40,00
Scadenza2026-01-16
Min-Max giorno3,5000 - 3,5000
Contratto - Min-MaxN/D
Volume2
Open Interest3,34k
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri